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Case Report

Cell-based therapy and rehabilitation with prosthetic limbs in a dog
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Abstract: A 5-year-old male dog was presented with the complaint of a chronic nonhealing wound on both hind legs. The wound
occurred during a serious train accident that caused loss of both hind limbs below the hock joint. Since then, the wound did not respond
to any standard treatment for up to 4 months. Again it was dressed for 15 days, but it did not show any improvement. With the consent
of the owner, cell-based therapy was conducted by collecting bone marrow from the proximal anteromedial aspect of the tibia. After
the application of bone marrow derived mesenchymal stem cells (BM-MSCs) the time to complete healing was 24 days. Due to pressure
at the bony cut stump, the dog was noted to have pain while walking, and walked on his forelegs. An artificial limb was subsequently
applied. The dog managed to walk normally after several days of training.
Key words: Chronic nonhealing wound, BM-MSCs, dog, rehabilitation

1. Introduction
Wound healing is a highly complex process. It is a matter
of major concern for clinicians (1), and has always been
a challenge for veterinarians. In comparison to human
wounds, animal wound care is challenging due to the
very nature and behavior of habit and habitat, which lead
to a greater degree of wound complication and infection
(2). Nonhealing or slow-healing ulcers represent a major
health burden and drain on resources (3), contributing
to substantial disability and morbidity (4,5). Chronic
nonhealing wounds continue to pose a challenge not only
to the physician, but also to the community and society as
a whole.
Optimum healing of a cutaneous wound requires
a well-orchestrated integration of complex biological
and molecular events of cell migration, proliferation,
extracellular matrix (ECM) deposition, angiogenesis, and
remodeling (6–9). In the field of regenerative medicine,
clinical trials suggest that direct application of autologous
bone marrow cultured cells may accelerate the healing of
nonhealing chronic ulcers (10,11). Bone marrow (BM)
contains nonhematopoietic mesenchymal stem cells
(MSCs) capable of differentiating into cells of numerous
tissue lineages (12). These cells also possess a distinctive
ability to renew themselves by mitotic division and to
* Correspondence: drjohndas@gmail.com

differentiate into a wide spectrum of cells, as seen during
embryonic development (13).
2. Case history
A 5-year-old, male, Himalayan, long-haired breed dog
was presented with severely wounded nonhealing hind
limbs amputated above the hock region (Figure 1).
History revealed that the dog had been injured during
transportation by train, and was subsequently treated with
several standard therapeutic regimens for 4 months without
any favorable result. Based on the characteristics of the
wound, regenerative medicine, such as stem cell therapy,
was chosen as a therapeutic maneuver. With proper consent
from the owner, autologous bone marrow derived from
mesenchymal stem cell (BM-MSCs) therapy was planned.
3. Treatment
Under injectable general anesthesia using atropine,
xylazine, and ketamine, the proximal anteromedial aspect of
tibia was prepared aseptically for bone marrow aspiration.
A 1-cm cutaneous skin incision was made at the proposed
site, and the bone was drilled through the incision with an
electrical orthopedic drill bit of 2 mm diameter. Then 10
mL of BM was aspirated into a sterile syringe primed with
EDTA (Himedia, India) at 1 mg/mL. The BM aspiration
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undisturbed for 20 min for proper adherence of the
implanted MSCs and were then bandaged with a paraffin
wet bandage. During the study, a bacteriological swab was
taken to determine the load of microorganisms at the site
of the wound. Blood and tissue samples were collected for
hematobiochemical, histochemical, and histopathological
study. Physical parameters (wound dimension, type and
extent of exudates, swelling, and wound contraction) and
clinical parameters (rectal temperature, pulse, respiration,
and character of visible mucous membrane) were studied.
A sequential photographic record was maintained. Painfree walking distance was also measured during the study.
Figure 1. Wound at the time of presentation.

was performed according to the method of Crow and
Walshaw (14). The BM-derived nucleated cells (BMNCs) were collected from aspirate by volume reduction
protocol according to the method of Kasten et al. (15). The
EDTA-mixed bone marrow was dispatched for culture
and growth to the stem cell laboratory of the Central
Institute of Freshwater Aquaculture (CIFA), Odisha,
India. The conditioned media were prepared for culture
with commercially available basic ingredients (Table).
The collected bone marrow was layered over Histopaque
(Sigma-Aldrich, USA) for the isolation of mononuclear
cells, and was centrifuged at 2000 rpm for 20 min. The
monocytes in the buffy layer were seeded onto a 0.1%
gelatin-coated 6-well plate (Tarson, India), and 100 µL of
cells were poured into a 6-well plate containing 2 mL of
composed media at 37 °C and 5% CO2 in the CO2 incubator
(Contherm Scientiﬁc Ltd, USA). The medium was changed
regularly and cell morphology was examined under a Nikon
phase contrast microscope (Figure 2). After complete
colony formation and the attainment of confluence, the
cultured cells were removed for therapeutic application.
The BM-MSCs were injected intradermally and applied
topically at the wound margin and at different points in the
wound bed (Figure 3). The wound sites were maintained

4. Results and discussion
Ciprofloxacin was administered parenterally along with
regular sterile dressing before stem cell application, as
per the antibiogram. BM was collected from the proximal
anteromedial aspect of the tibia, because of its superficial
position with thin covering tissue and ease of collection
compared to other sites. The moist wound environment
allows optimal healing by hastening debridement
and promoting granulation tissue formation and fast
epithelialization (16). Hence, after application of BMMSCs, the wound was bandaged with a paraffin wet
bandage to create a better environment for healing and
to prevent leakage of MSCs. There was no significant
difference in physiological, hematological, or biochemical
parameters during the study. Significant improvement
in physical parameters was observed during the healing
period. Pain-free walking distance gradually increased.
Histopathology after therapy showed neovascularization
(Figure 4) with appearance of fibroblasts, sebaceous
glands, and epithelialization, which supported the
progression of the healing process (6–8). Histochemical
study showed increased collagen content after stem cell
therapy. The collagen content with Sircol assay kit method
on days 0, 14, and 16 were 12.76, 24.82, and 28.69 µg/
mg, respectively, which supports the findings reported by
Ghani et al. (17), Pascoe (18), Curtis (19), and Singh and
Singh (20) regarding wound healing. The photographs

Table. Constituents of the composed media.
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Constituents of media

Amount

FBS (Fetal Bovine Serum) 10%, Lonza
Sodium Pyruvate 0.1%, Himedia
NEA (Nonessential amino acids) 0.1%, Himedia
DMEM (Dulbecco-modified Eagle medium) (MP pharmaceuticals)
Streptomycin (Sigma-Aldrich)
L 15 (Livosys 15) washing media
Total

5 mL
0.5 mL
0.5 mL
18.5 mL
0.5 mL
25 mL
50 mL
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Figure 2. A 40× photomicrograph of cultured BM cells on day 7.

Figure 3. Application of BM-MSCs by intradermal injection.

of the wound were evaluated by 3 surgeons according to
Borena et al. (21), and showed complete healing on day 24
(Figure 5). The healing of cutaneous wounds is mediated by
the regenerative effects of the transforming growth factor
(TGF), fibroblast growth factor (FGF), fibronectin-like
peptide, keratinocytes growth factor, epidermal growth

Figure 4. Formation of granulation tissue and abundant
neovascularization after application of BM-MSCs.

Figure 5. Wound after 24 days of BM-MSCs application.

factor, and growth hormone releasing factors (22). In
this case, all these factors were possibly accelerated due
to the application of MSCs. The role of MSCs in wound
healing is attributed to their ability not only to differentiate
but also to produce various angiogenic factors such as
vascular endothelial growth factor (VEGF) and basic
fibroblast growth factor (bFGF) (23). On day 24 of stem
cell therapy, the dog was able to walk moderately following
bandaging of the amputated sites (Figure 6). A synthetic
shoe was applied as a protective pad to prevent injury to
the freshly healed wounds (Figure 7). As a rehabilitation
measure, the dog was tried with a wheel cart, but did not
accept it for regular use. As a result, it was taken to the
National Institute of Rehabilitation Training and Research
(NIRTAR), Odisha, India, and a clinical trial was performed
with an artificial prosthetic limb (Figure 8). Following 20
days of rehabilitation and training, the dog was able to
adopt the prosthetic limbs for regular use. Rehabilitation
was followed by 6 months of therapy, and no remarkable
untoward effect was noticed. With the application of
BM-MSCs and rehabilitation with artificial limbs, the

Figure 6. Application of bandage over amputated end.
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Figure 7. Application of shoes.

injured dog regained mobility and recovered. The stem cell
therapy in this study has been shown to be a simple, safe,
effective, quick, and nonreactive procedure that can be

Figure 8. Application of artificial limbs.

employed for large-scale application. The artificial limb can
also be adopted as a substitute for the wheel cart used for the
normal mobility of companion animals.

References
1.

Shrivastava PP, Chandrapuria VP, Bhargava MK, Malik MR.
Efficacy of indigenous plants on healing of experimental wounds
in cow calves: clinico-histomorphological and histochemical
observations. Indian J Vet Surg 2002; 23: 45–46.

12.

Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC.
Targeting nonhealing ulcers of lower extremity in human
through autologous bone marrow-derived mesenchymal stem
cells. Rejuv Res 2009; 12: 359–365.

2.

Bose VSC, Pattnaik TK, Bisoi PC, Mohapatra HK. Evaluation
of Skin Heal spray for wound healing in domestic animals.
Livestock International 2006; 11–16.

13.

3.

Harding KG, Morris HL, Patel GK. Healing of chronic wounds.
Brit Med J 2002; 324: 160–163.

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak
DR. Multilineage potential of adult human mesenchymal stem
cells. Science 1999; 284: 143–147.

14.

4.

Lown I, Kurt T, Tran H, Wayne M, Santiago C, Cioroiu M,
Grossi R. Does bilayered extracellular matrix technology hasten
wound healing in venous stasis ulcers? A retrospective study.
Wounds 2005; 17: 27–31.

Crow SE, Walshaw SO. Manual of Clinical Procedures in the
Dog, Cat, and Rabbit. 2nd ed. Hoboken, NJ, USA: Wiley; 1997.

15.

5.

Philips TJ. Chronic cutaneous ulcers: etiology and epidemiology.
J Invest Dermatol 1994; 102: 38–41.

Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA,
Zimmermann G, Lubinbühl R. Instant stem cell therapy:
characterization and concentration of human mesenchymal
stem cells in vitro. Eur Cells Mater 2008; 16: 47–55.

16.

6.

Martin P. Wound healing aiming for perfect skin regeneration.
Science 1997; 276: 75–81.

7.

Falanga V. Wound healing and its impairment in the diabetic
foot. Lancet 2005; 366: 1736–1743.

Fossum TW, Hedlund CS, Hulse DA, Johnson AL, Seim HB,
Willard MD, Carroll GL. Surgery of integumentary system.
In: Welch Fossum T, Hedlund CS, editors. Manual of Small
Animal Surgery. 2nd ed. Maryland Heights, MO, USA: Mosby;
1997. pp. 132–228.

8.

Singer AJ, Clark RAF. Cutaneous wound healing. New Engl J
Med 1999; 341: 738–746.

17.

Ghani A, Pandey SK, Kolte GN. Histological and histochemical
evaluation of certain local medicaments as accelerator of
wound healing. Indian J Indig Med. Suppl 1981; 2: 37–43.

9.

Wu Y, Chen L, Scott G, Tredget EE. Mesenchymal stem
cells enhance wound healing through differentiation and
angiogenesis. Stem Cells 2007; 25: 2648–2659.

18.

Pascoe JR. Wound healing. In: Gourley IM, Vasseur PB,
editors. General Small Animal Surgery. Philadelphia, PA, USA:
Lippincott; 1985. pp. 105–119.

10.

Badiavas EV, Falanga V. Treatment of the chronic wounds with
bone marrow-derived cells. Arch Dermatol 2003; 139: 510–516.

19.

11.

Bartsch T, Brehm M, Falke T, Kögler G, Wernet P, Strauer
BE. Rapid healing of a therapy-refractory diabetic foot after
transplantation of autologous bone marrow stem cells. Med Klin
2005; 100: 676–680 (article in German with an English abstract).

Curtis W. Wound healing. In: Slatter D, editor. Textbook
of Small Animal Surgery. 2nd ed. Philadelphia, PA, USA:
Saunders; 1993. pp. 53.

20.

Singh H, Singh K. Wound healing and tissue repair. In: Tyagi
RPS, Singh J, editors. Ruminant Surgery. 1st ed. New Delhi,
India: CBS Publishers; 2010. pp. 58–71.

118

DAS et al. / Turk J Vet Anim Sci
21.

Borena BM, Pawde AM, Amarpal, Aithal HP, Kinjavdekar
P, Singh R, Kumar D. Evaluation of healing potential of
autologous bone marrow derived nucleated cells on incisional
wounds in dogs. Indian J Vet Surg 2009; 30: 85–89.

22.

Wu CH, Chang GY, Chang WC, Hsu CT, Che RS. Wound
healing effects of porcine placental extracts on rats with
thermal injury. Brit J Dermatol 2003; 148: 236–45.

23.

Al-Khalidi A, Al-Sabiti H, Galipeau J, Lachapella K.
Therapeutic angiogenesis using autologous bone marrow
stromal cells improved blood flow in chronic limb ischemia
model. Ann Thorac Surg 2003; 75: 204–209.

119

